Consequently, these two different Cx43 mimetic peptides, GAP26 and TAT-GAP19, had different effects on LPS-induced hemichannel activation in vitro, and varied impacts on the outcomes of lethal sepsis in vivo (56). This evidence concerns the gene GJA1 and Sepsis.